Filing Details
- Accession Number:
- 0001415889-24-028350
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 21:40:07
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 21:40:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Ars Pharmaceuticals Inc. | SPRY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1551891 | Laura Shawver | C/O Ars Pharmaceuticals, Inc. 11682 El Camino Real, Suite 120 San Diego CA 92130 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 67,616 | $1.27 | 277,962 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 29,628 | $1.27 | 307,590 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 96,343 | $13.55 | 211,247 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-02 | 901 | $14.34 | 210,346 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-03 | 25,606 | $1.27 | 235,952 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-12-03 | 62,378 | $3.15 | 298,330 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-03 | 87,984 | $13.26 | 210,346 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-04 | 14,772 | $3.15 | 225,118 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-04 | 14,772 | $13.75 | 210,346 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 29,628 | $0.00 | 29,628 | $1.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 67,616 | $0.00 | 67,616 | $1.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-03 | 25,606 | $0.00 | 25,606 | $1.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-03 | 62,378 | $0.00 | 62,378 | $3.15 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-04 | 14,772 | $0.00 | 14,772 | $3.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,606 | 2030-04-28 | No | 4 | M | Direct | |
| 0 | 2030-04-28 | No | 4 | M | Direct | |
| 0 | 2030-04-28 | No | 4 | M | Direct | |
| 73,836 | 2032-05-01 | No | 4 | M | Direct | |
| 59,064 | 2032-05-01 | No | 4 | M | Direct |
Footnotes
- The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.
- The weighted average sale price for the transaction reported was $13.5539 and the range of prices were between $13.27 and $14.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $14.3417 and the range of prices were between $14.2761 and $14.375. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $13.2626 and the range of prices were between $12.92 and $13.62. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $13.7496 and the range of prices were between $13.39 and $14.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Immediately exercisable.
- Due to a clerical error, the total number of shares subject to this option grant was underreported by one share on the Reporting Person's Form 3 and is corrected on this filing.
Billionaire Hedge Funds
